Probiodrug secures $19.5 million in venture financing - MarketLine Financial Deals

Probiodrug secures $19.5 million in venture financing

Probiodrug secures $19.5 million in venture financing - MarketLine Financial Deals
Probiodrug secures $19.5 million in venture financing
Published Jan 04, 2012
4 pages — Published Jan 04, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Probiodrug AG, a Germany-based biopharmaceutical company, has secured EUR15 million ($19.50 million) in additional financing for the ongoing development of its glutaminyl cyclase (QC) inhibitor program.

  
Source:
Document ID
MA93965_120106
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Probiodrug secures $19.5 million in venture financing" Jan 04, 2012. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Probiodrug-secures-19-5-million-in-venture-financing-2052-75754>
  
APA:
MarketLine Financial Deals. (2012). Probiodrug secures $19.5 million in venture financing Jan 04, 2012. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Probiodrug-secures-19-5-million-in-venture-financing-2052-75754>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.